MDT
Medtronic plc
Overview
Medtronic plc manufactures and sells device-based medical therapies and services across four segments: Cardiovascular Portfolio (implantable heart devices, valve replacements, coronary stents), Neuroscience Portfolio (spinal implants, brain stimulation, stroke treatment devices), Medical Surgical Portfolio (surgical instruments, robotic surgery systems, patient monitoring), and Diabetes Operating Unit (insulin pumps, glucose monitors).
Medtronic plc is a Healthcare company operating in Medical Devices with a $101.05B market cap.
Most recent earnings call: Q1 FY26 on Aug 19, 2025.
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2025-08-1910 Q&A exchanges
- Q4 FY2025Earnings2025-05-2122 Q&A exchanges
- Q3 FY2025Earnings2025-02-1817 Q&A exchanges
- Q2 FY2025Earnings2024-11-1929 Q&A exchanges
- Q1 FY2025Earnings2024-08-2024 Q&A exchanges
- Q4 FY2024Earnings2024-05-2330 Q&A exchanges
- Q3 FY2024Earnings2024-02-2022 Q&A exchanges
- Q2 FY2024Earnings2023-12-0827 Q&A exchanges
- Q1 FY2024Earnings2023-08-2229 Q&A exchanges
- Q4 FY2023Earnings2023-05-2544 Q&A exchanges
- Q3 FY2023Earnings2023-02-2117 Q&A exchanges
- Q2 FY2023Earnings2022-11-2230 Q&A exchanges
- Q1 FY2023Earnings2022-08-2315 Q&A exchanges
- Q4 FY2022Earnings2022-05-2621 Q&A exchanges
- Q3 FY2022Earnings2022-02-2223 Q&A exchanges
- Q2 FY2022Earnings2021-11-2311 Q&A exchanges
- Q1 FY2022Earnings2021-08-2422 Q&A exchanges
- Q4 FY2021Earnings2021-05-2729 Q&A exchanges
- Q3 FY2021Earnings2021-02-2332 Q&A exchanges
- Q2 FY2021Earnings2020-11-2435 Q&A exchanges
- Q1 FY2021Earnings2020-08-2518 Q&A exchanges
History
Earnings history
Reported quarters with consensus, surprise, and 1-day reaction context.
Track Record
SampleSpoken Alpha tracks MDT's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 50% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $6.38 | $4.39 | +45.3% | +1.3% | +1.1% |
| Q4 FY2026 | $5.72 | $4.37 | +30.9% | -5.7% | -7.3% |
| Q3 FY2026 | $6.04 | $4.26 | +41.9% | +2.9% | +5.6% |
| Q2 FY2026 | $5.79 | $4.25 | +36.3% | +1.4% | +0.2% |
| Q1 FY2025 | $5.90 | $4.37 | +34.9% | -6.6% | -5.9% |
| Q4 FY2025 | $5.89 | $4.48 | +31.4% | +2.1% | +4.3% |
| Q3 FY2025 | $6.10 | $4.49 | +35.9% | -4.8% | -2.4% |
| Q2 FY2025 | $6.09 | $4.55 | +33.8% | -4.1% | -3.0% |
| Q1 FY2024 | $6.35 | $4.45 | +42.6% | -5.7% | -6.6% |
| Q4 FY2024 | $6.08 | $4.61 | +31.9% | +3.6% | +6.6% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Geoffrey MarthaCEO10 mo7 callsCurrentSample
CEO since 2025 • 2/4 beats (50%) • last call held guidance Q1 FY2026
- Thierry PietonCFO3 mo2 callsCurrentSample
CFO since 2026 • 2/2 beats (100%) • last guidance cut Q3 FY2026
- Harry Skip KiilPresident10 mono recorded callsCurrentSample
PRESIDENT since 2025 • 3/4 beats (75%) • last call held guidance Q3 FY2026
- Denise L BlomquistChief Accounting Officer10 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 3/4 beats (75%) • guidance suspended Q3 FY2026
- Matthew R WalterSVP, Chief HR Officer11 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last guidance raise Q1 FY2026
- Michael MarinaroEVP, Pres MedSurg and Americas10 mo7 callsCurrentSample
DIVISION_HEAD since 2025 • 3/4 beats (75%) • last guidance cut Q1 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for MDT.
$ curl https://api.spokenalpha.com/v1/companies/MDTFAQ
Frequently asked about MDT
Where can I find Medtronic plc's (MDT) earnings call transcripts?
Spoken Alpha indexes MDT's earnings call transcripts at https://spokenalpha.com/companies/MDT. Each call links to attributed speakers and parsed analyst Q&A.
When was Medtronic plc's most recent earnings call?
Medtronic plc (MDT) held its most recent earnings call on 2025-08-19, covering fiscal Q1 2026.
What sector is MDT in?
Medtronic plc (MDT) operates in the Healthcare sector (Medical Devices industry).